Kaweh Shakery

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized Study.

Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized Study.

Journal: Dermatology and therapy
Published: April 25, 2025

Safety and efficacy of inhaled PEG-ADM in ARDS patients: a randomised controlled trial.

Safety and efficacy of inhaled PEG-ADM in ARDS patients: a randomised controlled trial.

Journal: Critical care (London, England)
Published: March 21, 2025

Understanding Causes of Death in Patients With Acute Respiratory Distress Syndrome: A Narrative Review.

Understanding Causes of Death in Patients With Acute Respiratory Distress Syndrome: A Narrative Review.

Journal: Critical care explorations
Published: August 22, 2024

An empirically generated responder definition for rosacea treatment.

An empirically generated responder definition for rosacea treatment.

Journal: Clinical, cosmetic and investigational dermatology
Published: September 22, 2017

Patient-reported outcomes of azelaic acid foam 15% for patients with papulopustular rosacea: secondary efficacy results from a randomized, controlled, double-blind, phase 3 trial.

Patient-reported outcomes of azelaic acid foam 15% for patients with papulopustular rosacea: secondary efficacy results from a randomized, controlled, double-blind, phase 3 trial.

Journal: Cutis
Published: November 23, 2016

Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trial.

Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trial.

Journal: Cutis
Published: November 05, 2016

Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs.

Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs.

Journal: Skin pharmacology and physiology
Published: July 05, 2016

A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea.

A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea.

Journal: Cutis
Published: August 06, 2015

Postadolescent acne in females.

Postadolescent acne in females.

Journal: Skin pharmacology and physiology
Published: November 28, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026